Hatem E Sabaawy

Title: Hatem E Sabaawy: Innovator in Kidney Research

Introduction

Hatem E Sabaawy is a prominent inventor based in New Brunswick, NJ (US). He has made significant contributions to the field of biomedical research, particularly in the area of kidney health. With a total of 7 patents to his name, Sabaawy is recognized for his innovative approaches to treating kidney-related conditions.

Latest Patents

One of Sabaawy's latest patents is focused on "Single kidney cell-derived organoids." This invention relates to organoids derived from a single cell, such as a kidney cancer cell, and includes methods and compositions for their production and use. It also encompasses cell culture medium for producing organoids and methods of personalized treatment for kidney cancer. Additionally, the invention provides a humanized mouse that includes a kidney organoid derived from a patient's kidney cell.

Another notable patent is for "Expandable arrays and methods of use." This patent describes an expandable array and methods for maintaining a biological sample within it. The expandable array consists of multiple receptacles designed to receive a biological sample, along with a plurality of beams made from a programmable material. Each beam connects at least two receptacles and can transition between an extended state and a contracted state upon the application of a stimulus.

Career Highlights

Hatem E Sabaawy is affiliated with Rutgers, the State University of New Jersey, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on kidney cancer treatment and biological sample management.

Collaborations

Sabaawy has collaborated with notable colleagues, including David John Augeri and Howon Lee. These partnerships have contributed to the development of his innovative patents and research initiatives.

Conclusion

Hatem E Sabaawy is a distinguished inventor whose work in kidney research has led to significant advancements in the field. His innovative patents reflect his commitment to improving treatment options for kidney cancer and enhancing biological research methodologies.